ADMEDUS Vaccine's is moving along, Patent granted for "Expression system for modulating an immune response"
http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2008314485
- Forums
- ASX - By Stock
- AVR
- HSV-2 Clinical Trial
HSV-2 Clinical Trial, page-5
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.80 |
Change
-0.200(1.11%) |
Mkt cap ! $341.1M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $17.75 | $50.10K | 2.802K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | $17.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.90 | 262 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 17.800 |
1 | 26 | 17.740 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
17.900 | 262 | 3 |
17.910 | 36 | 2 |
17.930 | 31 | 2 |
17.950 | 270 | 2 |
18.000 | 300 | 1 |
Last trade - 14.55pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online